Velzatinib

N/A

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameVelzatinib
Drug Alias NameIDRX-42M-4205GSK-6042981
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsGastrointestinal NeoplasmsGastrointestinal Stromal Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[18] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesIDRx Inc
China Registration ClassN/A

Develop Information

Active CompaniesIDRx IncGlaxosmithkline PlcMerck Healthcare Kgaa +[6] 
Inactive CompaniesN/A
Active IndicationsGastrointestinal NeoplasmsGastrointestinal Stromal Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A